Disclosure Of Cash Flow Statement [Text Block]

BerGenBio - Filing #2542730

Concept As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
As at
2021-12-31
Disclosure of cash flow statement [text block]
Description of accounting policy for determining components of cash and cash equivalents [text block]
Cash and short-term deposits
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
156,421,000 NOK
150,803,000 NOK
436,646,000 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.